149 related articles for article (PubMed ID: 32871152)
1. Can Cross-Linked Siliconized PFS Come to the Rescue of the Biologics Drug Product?
Thakare V; Schmidt T; Rupprechter O; Leibold J; Stemmer S; Mischo A; Bhattacharjee D; Prazeller P
J Pharm Sci; 2020 Nov; 109(11):3340-3351. PubMed ID: 32871152
[TBL] [Abstract][Full Text] [Related]
2. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
[TBL] [Abstract][Full Text] [Related]
3. Methods To Determine the Silicone Oil Layer Thickness in Sprayed-On Siliconized Syringes.
Loosli V; Germershaus O; Steinberg H; Dreher S; Grauschopf U; Funke S
PDA J Pharm Sci Technol; 2018; 72(3):278-297. PubMed ID: 29343617
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of syringe surfaces on protein formulations.
Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
[TBL] [Abstract][Full Text] [Related]
5. Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System.
Shi GH; Gopalrathnam G; Shinkle SL; Dong X; Hofer JD; Jensen EC; Rajagopalan N
PDA J Pharm Sci Technol; 2018; 72(1):50-61. PubMed ID: 29030531
[TBL] [Abstract][Full Text] [Related]
6. Variables Impacting Silicone Oil Migration and Biologics in Prefilled Syringes.
Gentile K; Huang C; Liu X; Whitty-Léveillé L; Hamzaoui H; Cristofolli E; Rayfield W; Afanador NL; Mittal S; Krishnamachari Y; Xi H; Zhao X
J Pharm Sci; 2023 Aug; 112(8):2203-2211. PubMed ID: 37244516
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Syringe Age Prior to Filling on Migration of Subvisible Silicone-Oil Particles into Drug Product.
Song J; Hu G; Hamzaoui H; Krishnamachari Y; Persak SC; Xi H; Su Y
J Pharm Sci; 2022 Dec; 111(12):3191-3194. PubMed ID: 36404459
[TBL] [Abstract][Full Text] [Related]
9. Effect of Various Silicone Oil And Tungsten Levels on the Stability of a Monoclonal Antibody in Nine Commercially Available Prefilled Syringes.
Murphy MI; Leissa JA; Plata SB; Chamberlain AL; Patel SM
J Pharm Sci; 2023 Jun; 112(6):1586-1594. PubMed ID: 36933655
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
[TBL] [Abstract][Full Text] [Related]
11. Protein aggregation and particle formation in prefilled glass syringes.
Gerhardt A; Mcgraw NR; Schwartz DK; Bee JS; Carpenter JF; Randolph TW
J Pharm Sci; 2014 Jun; 103(6):1601-12. PubMed ID: 24729310
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of L-Asparaginase in Siliconized Syringes with Shaking and Headspace Air Induces Protein Aggregation.
Uchino T; Miyazaki Y; Ohkawa T; Yamazaki T; Yanagihara Y; Yoshimori T; Komatsu M; Suzuki H; Kagawa Y
Chem Pharm Bull (Tokyo); 2015; 63(10):770-9. PubMed ID: 26423033
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Silicone Oil in Prefilled Syringes and Biopharmaceutical Drug Products Using High-Performance Liquid Chromatography.
Liu J; Ronk M; Fujimori K; Lee H; Nashed-Samuel Y
AAPS PharmSciTech; 2021 Feb; 22(2):75. PubMed ID: 33585996
[TBL] [Abstract][Full Text] [Related]
14. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
[TBL] [Abstract][Full Text] [Related]
15. Introducing the Alba
Chillon A; Pace A; Zuccato D
PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
[TBL] [Abstract][Full Text] [Related]
16. Development of biotechnology products in pre-filled syringes: technical considerations and approaches.
Badkar A; Wolf A; Bohack L; Kolhe P
AAPS PharmSciTech; 2011 Jun; 12(2):564-72. PubMed ID: 21538214
[TBL] [Abstract][Full Text] [Related]
17. Method to Determine Syringe Silicone Oil Layer Heterogeneity and Investigation of its Impact on Product Particle Counts.
Cua M; Martin D; Meza P; Torraca G; Pearson T; Cao S; Yang C
J Pharm Sci; 2020 Nov; 109(11):3292-3299. PubMed ID: 32679217
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the initial level and migration of silicone oil lubricant in empty prefilled syringes for biologics using infrared spectroscopy.
Bee JS; Frey VV; Javed U; Chung J; Corcoran ML; Roussel PS; Krause SO; Cash PW; Bishop SM; Dimitrova MN
PDA J Pharm Sci Technol; 2014; 68(5):494-503. PubMed ID: 25336420
[TBL] [Abstract][Full Text] [Related]
19. Silicone oil-free syringes, siliconized syringes and needles: quantitative assessment of silicone oil release with drugs used for intravitreal injection.
Melo GB; da Cruz NFS; do Monte Agra LL; Emerson GG; Lima LH; Linkuviene V; Maia M; Farah ME; Carpenter JF; Rodrigues EB; Probst C
Acta Ophthalmol; 2021 Dec; 99(8):e1366-e1374. PubMed ID: 33890418
[TBL] [Abstract][Full Text] [Related]
20. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
